A fentanyl vaccine, under investigation in the Precision Vaccines Program, would prevent lethal overdoses by blocking fentanyl from entering the brain.
Shaping the future of pediatric medicine
For 150 years, Boston Children’s has been a driving force in pediatric innovation, pioneering breakthroughs that have reshaped medicine and transformed countless young lives. This legacy of discovery continues today, as we push the boundaries of pediatric research—empowering clinicians and scientists to challenge conventions and pursue better solutions for every child in our care.
As the world’s largest and most well-funded pediatric research enterprise, we provide unparalleled support for clinical studies at every level. Our comprehensive infrastructure ensures that research teams conduct groundbreaking, cost-effective investigations while keeping the patient-family experience at the heart of everything we do.
Image
Will people accept a fentanyl vaccine? Interviews draw thoughtful responses
Image
New insight into the effects of PPIs in children
Proton-pump inhibitors are frequently prescribed to treat reflux in children. Two studies provide insight into their risks.
Image
Immunotherapy for children with primary liver carcinomas: New hope
Checkpoint inhibitors might be an effective treatment option for a select group of pediatric patients with liver carcinomas.